And every other health concern associated with long COVID. The body does not continue to circulate spike protein once the viral infection has cleared. But the novel therapeutics, never before used in humans and absent any long term safety data have the ability to circulate spike proteins for at least 2 months.
"Myocarditis in response to COVID-19 vaccination has been reported since early 2021. ... We present a comprehensive histopathological analysis of endomyocardial biopsy from 15 patients with reduced ejection fraction (LVEF = 30 (14–39)%) and the clinical suspicion of myocarditis following vaccination with Comirnaty® (Pfizer-BioNTech) (n = 11), Vaxzevria® (AstraZenica) (n = 2) and Janssen® (Johnson & Johnson) (n = 2). Immunohistochemical endomyocardial biopsy analyses reveal myocardial inflammation in 14 of 15 patients.... The SARS-CoV-2 spike protein has been detected sparsely on cardiomyocytes of nine patients, and differential analysis of inflammatory markers such as CD4+ and CD8+ T cells suggests that the inflammatory response triggered by the vaccine may be of autoimmunological origin. ... The expression of SARS-CoV-2 spike protein within the heart and the dominance of CD4+ lymphocytic infiltrates indicate an autoimmunological response to the vaccination."
And every other health concern associated with long COVID. The body does not continue to circulate spike protein once the viral infection has cleared. But the novel therapeutics, never before used in humans and absent any long term safety data have the ability to circulate spike proteins for at least 2 months.
Myocarditis from Covid is a myth. All part of cover for the jabs.
Exactly!
Thank you for pointing out that article. Below is another good article to make the complete picture.
If anyone needs to talk with their doctor or employer, you can print out these articles instead of going empty-handed.
Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series (Baumeier et al., 2022. https://www.mdpi.com/1422-0067/23/13/6940 https://doi.org/10.3390/ijms23136940)
"Myocarditis in response to COVID-19 vaccination has been reported since early 2021. ... We present a comprehensive histopathological analysis of endomyocardial biopsy from 15 patients with reduced ejection fraction (LVEF = 30 (14–39)%) and the clinical suspicion of myocarditis following vaccination with Comirnaty® (Pfizer-BioNTech) (n = 11), Vaxzevria® (AstraZenica) (n = 2) and Janssen® (Johnson & Johnson) (n = 2). Immunohistochemical endomyocardial biopsy analyses reveal myocardial inflammation in 14 of 15 patients.... The SARS-CoV-2 spike protein has been detected sparsely on cardiomyocytes of nine patients, and differential analysis of inflammatory markers such as CD4+ and CD8+ T cells suggests that the inflammatory response triggered by the vaccine may be of autoimmunological origin. ... The expression of SARS-CoV-2 spike protein within the heart and the dominance of CD4+ lymphocytic infiltrates indicate an autoimmunological response to the vaccination."